Literature DB >> 14766268

Primary primitive neuroectodermal tumor of the uterus: a report of two cases and review of the literature.

Kunle Odunsi1, Moshood Olatinwo, Yvonne Collins, Matthew Withiam-Leitch, Shashikant Lele, Gregory W Spiegel.   

Abstract

BACKGROUND: Primary primitive neuroectodermal (pPNET) tumors rarely occur in adults, and they very rarely present as primary tumors of the uterus. Only 12 reported cases of pPNET of the uterus have been published in the English literature. We report two additional cases treated at the Roswell Park Cancer Institute, Buffalo, NY, between 1999 and 2002. CASES: Two postmenopausal patients presenting with abnormal uterine bleeding underwent endometrial biopsy, and subsequently staging laparotomy. The diagnosis of pPNET in both cases was confirmed only by extensive immunohistochemical analysis of the tumors. One patient with disease confined to an endometrial polyp received no adjuvant therapy, while the second patient with extrauterine disease received adjuvant pelvic radiation followed by chemotherapy.
CONCLUSIONS: The diagnosis of pPNET of the uterus may be a challenge. Features of diagnostic significance include positive staining with neuron-specific enolase, presence of neurosecretory granules, and positive staining with the MIC-2 gene. Currently, there is no uniformity in the treatment of these cases since the majority of the patients reported to date have had surgery, chemotherapy, and/or radiation therapy.

Entities:  

Mesh:

Year:  2004        PMID: 14766268     DOI: 10.1016/j.ygyno.2003.09.029

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  8 in total

1.  Uterine tumors with neuroectodermal differentiation. A report of 4 cases.

Authors:  Pavel Dundr; Daniela Fischerová; Ctibor Povýšil; Adéla Berková; Lenka Bauerová; David Cibula
Journal:  Pathol Oncol Res       Date:  2010-03-05       Impact factor: 3.201

2.  Primitive Neuroectodermal Tumors of the Female Genital Tract: A Morphologic, Immunohistochemical, and Molecular Study of 19 Cases.

Authors:  Sarah Chiang; Matija Snuderl; Sakiko Kojiro-Sanada; Ariadna Quer Pi-Sunyer; Dean Daya; Tohru Hayashi; Luisanna Bosincu; Fumihiro Ogawa; Andrew E Rosenberg; Lars-Christian Horn; Lu Wang; A John Iafrate; Esther Oliva
Journal:  Am J Surg Pathol       Date:  2017-06       Impact factor: 6.394

3.  Endometrial endometrioid adenocarcinoma associated with primitive neuroectodermal tumour of the uterus: a poor prognostic subtype of uterine tumours.

Authors:  Carla Bartosch; Joana Vieira; Manuel R Teixeira; José Manuel Lopes
Journal:  Med Oncol       Date:  2010-05-29       Impact factor: 3.064

4.  Uterine corpus tumor with neuroectodermal differentiation and frequent ganglion-like cells in a postmenopausal woman.

Authors:  Taku Homma; Takehiro Nakao; Toshiya Maebayashi; Toshiyuki Ishige; Hiroyuki Hao
Journal:  Gynecol Oncol Rep       Date:  2018-04-17

5.  Primary primitive neuroectodermal tumor of the cervix confirmed with molecular analysis in a pregnant woman: A case report and literature review.

Authors:  Ding Wei; Zhao Jianguo; Li Xiao; Qu Pengpeng
Journal:  Front Genet       Date:  2022-08-10       Impact factor: 4.772

6.  High grade primitive neuroectodermal tumor of the uterus: A case report.

Authors:  A Mitch Dizon; Larry C Kilgore; Alan Grindstaff; Marcus Winkler; Kristopher J Kimball
Journal:  Gynecol Oncol Case Rep       Date:  2013-10-19

7.  Central-type primitive neuroectodermal tumor of the uterus: Case report of remission of stage IV disease using adjuvant cisplatin/etoposide/bevacizumab chemotherapy and review of the literature.

Authors:  Jorge Novo; Pincas Bitterman; Alfred Guirguis
Journal:  Gynecol Oncol Rep       Date:  2015-09-16

Review 8.  Clinical management of a unique case of PNET of the uterus during pregnancy, and review of the literature.

Authors:  Rosalba De Nola; Edoardo Di Naro; Luca Maria Schonauer; Giuseppe Lucarelli; Michele Battaglia; Maria Grazia Fiore; Salvatore Andrea Mastrolia; Giuseppe Loverro
Journal:  Medicine (Baltimore)       Date:  2018-01       Impact factor: 1.889

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.